These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 28438346)

  • 1. Post-bronchodilator Reversibility of FEV
    Chou KT; Su KC; Hsiao YH; Huang SF; Ko HK; Tseng CM; Su VY; Perng DW
    Arch Bronconeumol; 2017 Oct; 53(10):547-553. PubMed ID: 28438346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of airway inflammation and bronchodilator reversibility in COPD: a potential guide to treatment.
    Perng DW; Huang HY; Chen HM; Lee YC; Perng RP
    Chest; 2004 Aug; 126(2):375-81. PubMed ID: 15302720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD.
    Negewo NA; McDonald VM; Baines KJ; Wark PA; Simpson JL; Jones PW; Gibson PG
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1495-504. PubMed ID: 27445469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled fluticasone and salmeterol suppress eosinophilic airway inflammation in chronic obstructive pulmonary disease: relations with lung function and bronchodilator reversibility.
    Perng DW; Wu CC; Su KC; Lee YC; Perng RP; Tao CW
    Lung; 2006; 184(4):217-22. PubMed ID: 17006748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
    Hastie AT; Martinez FJ; Curtis JL; Doerschuk CM; Hansel NN; Christenson S; Putcha N; Ortega VE; Li X; Barr RG; Carretta EE; Couper DJ; Cooper CB; Hoffman EA; Kanner RE; Kleerup E; O'Neal WK; Paine R; Peters SP; Alexis NE; Woodruff PG; Han MK; Meyers DA; Bleecker ER;
    Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchial hyperresponsiveness, airway inflammation, and reversibility in patients with chronic obstructive pulmonary disease.
    Zanini A; Cherubino F; Zampogna E; Croce S; Pignatti P; Spanevello A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1155-61. PubMed ID: 26124655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.
    Brightling CE; Bleecker ER; Panettieri RA; Bafadhel M; She D; Ward CK; Xu X; Birrell C; van der Merwe R
    Lancet Respir Med; 2014 Nov; 2(11):891-901. PubMed ID: 25208464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The success and safety profile of sputum induction in patients with chronic obstructive pulmonary disease: An Indian experience.
    Fernandes L; Mesquita AM
    Indian J Tuberc; 2017 Jul; 64(3):201-205. PubMed ID: 28709489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.
    Brightling CE; McKenna S; Hargadon B; Birring S; Green R; Siva R; Berry M; Parker D; Monteiro W; Pavord ID; Bradding P
    Thorax; 2005 Mar; 60(3):193-8. PubMed ID: 15741434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exhaled Hydrogen Sulfide Predicts Airway Inflammation Phenotype in COPD.
    Zhang J; Wang X; Chen Y; Yao W
    Respir Care; 2015 Feb; 60(2):251-8. PubMed ID: 25336529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between expressions of myeloperoxidase and eosinophil cationic protein in sputum and clinical features of asthma-chronic obstructive pulmonary disease overlap].
    Yang H; Zhang Y; Zhang J; Pan J; Wang F; Luo X; Chen F
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1215-1221. PubMed ID: 30377121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Airway inflammation and mannitol challenge test in COPD.
    de Nijs SB; Fens N; Lutter R; Dijkers E; Krouwels FH; Smids-Dierdorp BS; van Steenwijk RP; Sterk PJ
    Respir Res; 2011 Jan; 12(1):11. PubMed ID: 21241520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between Blood and Induced Sputum Eosinophils, Bronchial Hyperresponsiveness and Reversibility of Airway Obstruction in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.
    Proboszcz M; Mycroft K; Paplinska-Goryca M; Górska K; Nejman-Gryz P; Jankowski P; Zak N; Krenke R
    COPD; 2019 Dec; 16(5-6):354-361. PubMed ID: 31631716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma.
    Kitaguchi Y; Komatsu Y; Fujimoto K; Hanaoka M; Kubo K
    Int J Chron Obstruct Pulmon Dis; 2012; 7():283-9. PubMed ID: 22589579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can we predict sputum eosinophilia from clinical assessment in patients referred to an adult asthma clinic?
    Yap E; Chua WM; Jayaram L; Zeng I; Vandal AC; Garrett J
    Intern Med J; 2013 Jan; 43(1):46-52. PubMed ID: 21790924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring COPD patients: systemic and bronchial eosinophilic inflammation in a 2-year follow-up.
    Pignatti P; Visca D; Zappa M; Zampogna E; Saderi L; Sotgiu G; Centis R; Migliori GB; Spanevello A
    BMC Pulm Med; 2024 May; 24(1):247. PubMed ID: 38764008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of a New Algorithm to Identify Asthma-COPD Overlap (ACO) Patients in a Cohort of Patients with Chronic Obstructive Airway Disease.
    Pérez de Llano L; Cosío BG; Miravitlles M; Plaza V;
    Arch Bronconeumol (Engl Ed); 2018 Apr; 54(4):198-204. PubMed ID: 29229474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
    Siva R; Green RH; Brightling CE; Shelley M; Hargadon B; McKenna S; Monteiro W; Berry M; Parker D; Wardlaw AJ; Pavord ID
    Eur Respir J; 2007 May; 29(5):906-13. PubMed ID: 17301099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma-COPD overlap.
    Gao J; Zhou W; Chen B; Lin W; Wu S; Wu F
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2703-2710. PubMed ID: 28979112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD).
    Grootendorst DC; Gauw SA; Benschop N; Sterk PJ; Hiemstra PS; Rabe KF
    Pulm Pharmacol Ther; 2003; 16(6):341-7. PubMed ID: 14580925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.